As global markets face economic uncertainties and stock indices experience significant declines, the Swedish market remains a focal point for investors seeking resilient growth opportunities. In this environment, companies with high insider ownership often signal strong confidence from those who know the business best, making them attractive candidates for long-term growth investments.
Name | Insider Ownership | Earnings Growth |
CTT Systems (OM:CTT) | 16.9% | 24.8% |
Truecaller (OM:TRUE B) | 29.5% | 21.6% |
Fortnox (OM:FNOX) | 21.1% | 22.6% |
Magle Chemoswed Holding (OM:MAGLE) | 14.9% | 72.2% |
Biovica International (OM:BIOVIC B) | 18.8% | 73.1% |
BioArctic (OM:BIOA B) | 34% | 98.4% |
Yubico (OM:YUBICO) | 37.5% | 42.5% |
KebNi (OM:KEBNI B) | 37.8% | 86.1% |
InCoax Networks (OM:INCOAX) | 19.3% | 115.5% |
C-Rad (OM:CRAD B) | 16.1% | 33.9% |
Click here to see the full list of 91 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.
We're going to check out a few of the best picks from our screener tool.
Simply Wall St Growth Rating: ★★★★★★
Overview: BioArctic AB (publ) develops biological drugs for central nervous system disorders in Sweden and has a market cap of SEK 16.08 billion.
Operations: BioArctic AB (publ) generates revenue primarily from its biotechnology segment, amounting to SEK 299.35 million.
Insider Ownership: 34%
Return On Equity Forecast: 28% (2027 estimate)
BioArctic, a Swedish biotech firm, showcases significant growth potential with high insider ownership. The company is forecast to achieve profitability within three years and expects annual revenue growth of 42.4%, outpacing the market. Recent earnings reveal substantial sales increases despite ongoing net losses. Key product developments include promising Phase 1 results for exidavnemab and multiple global approvals for Leqembi®, an Alzheimer's treatment, highlighting BioArctic's innovative capabilities in neurodegenerative diseases.
Simply Wall St Growth Rating: ★★★★★★
Overview: CTT Systems AB (publ) designs, manufactures, and sells humidity control systems for aircraft in Sweden, Denmark, France, the United States, and internationally with a market cap of SEK 3.40 billion.
Operations: The company's revenue segment primarily comes from Aerospace & Defense, amounting to SEK 317.70 million.
Insider Ownership: 16.9%
Return On Equity Forecast: 44% (2027 estimate)
CTT Systems demonstrates strong growth potential with high insider ownership. The company reported Q2 2024 sales of SEK 83.1 million, up from SEK 79.5 million a year ago, and expects net sales for the second half of 2024 to increase by up to 16%. Revenue and earnings are forecasted to grow significantly faster than the Swedish market, at rates of 21.9% and 24.8% per year respectively. Insider activity has been positive with substantial buying in the past three months.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Haypp Group AB (publ) is an online retailer specializing in tobacco-free nicotine pouches and snus products across Sweden, Norway, the rest of Europe, and the United States, with a market cap of SEK2.75 billion.
Operations: Haypp Group AB (publ) generates revenue primarily from two segments: Core, contributing SEK2.49 billion, and Growth, adding SEK929.04 million.
Insider Ownership: 10.9%
Return On Equity Forecast: N/A (2027 estimate)
Haypp Group, a growth company with high insider ownership, reported Q2 2024 revenue of SEK 950.95 million, up from SEK 777.79 million a year ago. Earnings are forecasted to grow significantly at 112.9% per year, outpacing the Swedish market's expected growth of 15.3%. The company targets SEK 5 billion in revenue for 2025 and trades at a substantial discount to its estimated fair value. However, shareholders have experienced dilution over the past year.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include OM:BIOA B OM:CTT and OM:HAYPP.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。